当前位置:首页 >财报库 > 报告详情

百时美施贵宝Bristol Myers Squibb(BMY)2024年年度报告「NYSE」(英文版)(106页).pdf

上传人: Kell****reet 编号:652444 2025-05-14 106页 48.97MB

下载:

1、2024 ANNUAL REPORT 2025 Bristol-Myers Squibb Company.All rights reserved.In 2024,Bristol Myers Squibb marked the 10th anniversary of Global Patient Week,an event that connects employees with patients,celebrating these inspiring individuals who are at the heart of the companys mission.This week-long

2、celebration brings patients to Bristol Myers Squibb facilities around the world,offering them the opportunity to share their stories and meet the dedicated individuals who contribute to their fight against disease.Global Patient Week serves as a powerful reminder of what Bristol Myers Squibb employe

3、es strive for daily across all functions,locations and countries keeping patients at the heart of their work.A question often asked of new employees is,“Who are you working for?”For most of our colleagues,the answer is personal many have loved ones either waiting for a life-saving medicine or who ha

4、ve benefitted from one.Anchoring ourselves to this who provides a deeply personal connection to BMSs mission of transforming lives through science.Every day,we are inspired by the opportunity to deliver life-changing medicines and provide patients with hope.Scan the QR Code to learn more about the B

5、ristol Myers Squibb Global Patient Week.Our MissionTo discover,develop and deliver innovative medicines that help patients prevail over serious diseasesOur VisionTo be the worlds leading biopharma company that transforms patients lives through scienceOur ValuesIntegrity Innovation Urgency Passion Ac

6、countability InclusionBristol Myers Squibb 2024 Annual ReportContinued on next page.A History of TransformationSince our founding,one thing has been clear:Bristol Myers Squibb is in the business of transformation.Were known for transforming patients lives through the delivery of innovative medicines

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据报告的内容,本文主要介绍了2024年Bristol Myers Squibb公司的年度报告。报告内容包括: 1. 公司简介:Bristol Myers Squibb是一家全球领先的生物制药公司,致力于通过科学改变患者的生活。 2. 2024年业绩:公司实现了7%的总收入增长,并在增长组合中实现了双位数的收入增长。 3. 研发进展:公司在2024年取得了多项重要研发进展,包括美国FDA批准和上市Cobenfy,这是近几十年来精神分裂症首个新作用机制的药物。 4. 运营效率:公司采取措施提高运营效率,计划到2025年底实现15亿美元的成本节约。 5. 资本配置:公司通过收购Karuna Therapeutics、RayzeBio和Mirati Therapeutics等公司,加强其产品组合,并偿还债务,增强了公司的财务状况。 6. 股东回报:公司宣布2025年将提高季度股息3.3%,这是连续第93年支付股息。 7. 未来展望:公司预计在2025年至2030年间,将实现显著的增长潜力。
2024年,百时美施贵宝公司如何庆祝全球患者周? 百时美施贵宝公司的使命是什么? 百时美施贵宝公司如何通过运营卓越和战略资本配置实现长期增长?
客服
商务合作
小程序
服务号
折叠